The present invention relates to the use of formulations from Crataegus for the preparation of pharmaceutical preparations or food supplements for the prophylaxis and/or treatment of tumour diseases, the formulations substantially comprising constituents of Crataegus which are soluble in polar solvents. The invention furthermore relates to the use of Crataegus plant parts for the preparation or infusions. Compositions for the prophylaxis and/or treatment of tumour diseases are furthermore included.

Nativia Health Products GmbH

Use of crataegus formulations for prophylaxis and treatment of neoplastic diseases

Provided is a method of anticancer therapy comprising administering to an individual an herbal extract-based composition comprising an extract of Gynostemma pentaphyllum, an extract of Crataegus pinnatifida (hawthorn leaves or berries), and an extract of Camellia sinensis (green tea). In one embodiment, the anticancer therapy comprises administering to a tumor bearing individual a therapeutically effective amount of the composition. In a second embodiment, the anticancer therapy comprises administering to an individual, at risk of developing a tumor, a prophylactically effective amount of the composition.

crataegus gracilior/krabbamein

Use of crataegus formulations for prophylaxis and treatment of neoplastic diseases

Method for anticancer therapy using an herbal extract composition

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum